Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG)

@article{Curran1997BaselineQO,
  title={Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG)},
  author={Desmond Curran and Sophie D. Fossȧ and Neil K. Aaronson and Gwendoline M Kiebert and Frans Keuppens and R Hall},
  journal={European journal of cancer},
  year={1997},
  volume={33 11},
  pages={
          1809-14
        }
}
Quality of life (QoL) is now commonly studied in prostate cancer. However, little is known about the appropriateness of the various QoL instruments in this group of patients. The purpose of this work was to study the baseline QoL assessment of patients with prostate cancer who were randomised into three EORTC phase III studies. The three trials included locoregional prostate cancer patients, poor prognosis metastatic patients and hormone resistance patients, respectively. In the three trials… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 29 CITATIONS

Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients.

Quality of life with advanced metastatic prostate cancer.

VIEW 1 EXCERPT
CITES METHODS